Literature DB >> 29131126

Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin.

Andrea R Gilbert1, Wafik Zaky, Murat Gokden, Christine E Fuller, Eylem Ocal, Norman E Leeds, Gregory N Fuller.   

Abstract

Diffuse midline glioma, H3-K27M mutant (DMG-K27M) is a newly described, molecularly distinct infiltrative glioma that almost exclusively arises in midline CNS structures, including the brain stem, especially the pons, as well as the thalamus and spinal cord with rare examples seen in the cerebellum, third ventricle, and hypothalamus. To our knowledge, only 1 case of a molecularly confirmed DMG-K27M arising in the pineal region has been previously reported. We present the second occurrence of a tissue-confirmed DMG-K27M of the pineal region, which, to our knowledge, is the first case reported in a child and the first case with documented preoperative MRI. This case, in addition to a prior report described in an adult, defines the lower end of a broad age range of DMG-K27M onset (12-65 years) and establishes the pineal gland as a bona fide site of origin for this newly codified midline glioma.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Diffuse midline glioma; H3-K27M mutant; Pineal tumor

Mesh:

Year:  2017        PMID: 29131126     DOI: 10.1159/000481513

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  9 in total

Review 1.  2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.

Authors:  Cillian McNamara; Kshitij Mankad; Stefanie Thust; Luke Dixon; Clara Limback-Stanic; Felice D'Arco; Thomas S Jacques; Ulrike Löbel
Journal:  Neuroradiology       Date:  2022-07-22       Impact factor: 2.995

Review 2.  Pineal Gland Tumor Microenvironment.

Authors:  Joham Choque-Velasquez; Szymon Baluszek; Roberto Colasanti; Sajjad Muhammad; Juha Hernesniemi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.

Authors:  Randy S D'Amico; George Zanazzi; Peter Wu; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2018-07-10       Impact factor: 4.130

4.  Imaging characteristics of H3 K27M histone-mutant diffuse midline glioma in teenagers and adults.

Authors:  Stefanie Thust; Caroline Micallef; Sachi Okuchi; Sebastian Brandner; Atul Kumar; Kshitij Mankad; Stephen Wastling; Laura Mancini; Hans Rolf Jäger; Ananth Shankar
Journal:  Quant Imaging Med Surg       Date:  2021-01

5.  Long-term survival outcomes of pineal region gliomas.

Authors:  Joham Choque-Velasquez; Julio Resendiz-Nieves; Behnam Rezai Jahromi; Szymon Baluszek; Sajjad Muhammad; Roberto Colasanti; Juha Hernesniemi
Journal:  J Neurooncol       Date:  2020-07-01       Impact factor: 4.130

6.  Long-term survival of a patient with diffuse midline glioma in the pineal region: A case report and literature review.

Authors:  Takahiro Ono; Haruka Kuwashige; Jun-Ichi Adachi; Masataka Takahashi; Masaya Oda; Toshihiro Kumabe; Hiroaki Shimizu
Journal:  Surg Neurol Int       Date:  2021-12-14

7.  Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases.

Authors:  Linmao Zheng; Jing Gong; Tianping Yu; Yan Zou; Mengni Zhang; Ling Nie; Xueqin Chen; Qiang Yue; Yanhui Liu; Qing Mao; Qiao Zhou; Ni Chen
Journal:  Am J Surg Pathol       Date:  2022-04-13       Impact factor: 6.298

8.  Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.

Authors:  Rouzbeh Banan; Arash Akbarian; Majid Samii; Amir Samii; Helmut Bertalanffy; Ulrich Lehmann; Christian Hartmann; Roland Brüning
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

9.  Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.

Authors:  Peter Raab; Rouzbeh Banan; Arash Akbarian; Majid Esmaeilzadeh; Madjid Samii; Amir Samii; Helmut Bertalanffy; Ulrich Lehmann; Joachim K Krauss; Heinrich Lanfermann; Christian Hartmann; Roland Brüning
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.